Patent details

Basic Information

Publication number:

EP1961426

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP080755382

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Combined meningitis vaccines

French Title of Invention:

Vaccins combinés contre la méningite

German Title of Invention:

Kombinationsimpfstoffe gegen Meningitis

SPC Number:

Dates

Filing date:

04/10/2004

Grant date:

27/04/2011

EP Publication Date:

27/04/2011

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/08/2008

EP B1 Publication Date:

27/04/2011

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

04/10/2011

Expiration date:

04/10/2024

Renunciation date:

Revocation date:

14/09/2020

Annulment date:

Owner

From:

28/07/2017

 

 

Name:

GlaxoSmithKline Biologicals SA

Address:

Rue de l'Institut 89, 1330 Rixensart, Belgium (BE)

History of Owners

From:

09/06/2011

To:

28/07/2017

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

Name:

Contorni Mario c/o Novartis Vaccines

Address:

Italy (IT)

Priority

1

Priority Number:

0323102

Priority Date:

02/10/2003

Priority Country:

United Kingdom (GB)

2

Priority Number:

0412052

Priority Date:

28/05/2004

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

A61K 39/095;

Publication

European Patent Bulletin

1

Issue number:

201735

Publication date:

30/08/2017

Description:

Transfer of Rights

2

Issue number:

202045

Publication date:

04/11/2020

Description:

Revocation of the European patent

Filing date	Document type	Number of pages